NOVOZYMES BIOINDUSTRIAL A/S
CVR 24257908 · Public limited company (A/S) · Active · Low risk
NOVOZYMES BIOINDUSTRIAL A/S is a Public limited company (A/S), founded on , based in Bagsværd. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 24.9m and a net result of DKK -44k. CEO: Lisbet Kragelund.
Bankruptcy risk for NOVOZYMES BIOINDUSTRIAL A/S
0.0 × the average (1.41%) · higher risk than 0% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 24257908
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (52 years)
- Address
- Krogshøjvej 36
2880 Bagsværd - Municipality
- Gladsaxe
- Industry
- Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 4.6m
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 31 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 99.8% |
| Current ratio | 210% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 8 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -52k | DKK -51k | DKK -41k |
| Net profit | DKK -44k | DKK -42k | DKK -4.0m |
| Equity | DKK 24.9m | DKK 24.9m | DKK 25.0m |
| Total assets | DKK 24.9m | DKK 25.0m | DKK 25.0m |
| Short-term debt | DKK 49k | DKK 49k | – |
Latest annual report: Reporting class B · auditor's statement: Auditor's report on audited financial statements · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 154 | ||
| 1 Jan 2024 – 31 Dec 2024 | 171 | ||
| 1 Jan 2023 – 31 Dec 2023 | 173 | ||
| 1 Jan 2022 – 31 Dec 2022 | 159 | ||
| 1 Jan 2021 – 31 Dec 2021 | 182 | ||
| 1 Jan 2020 – 31 Dec 2020 | 180 | ||
| 1 Jan 2019 – 31 Dec 2019 | 176 | ||
| 1 Jan 2018 – 31 Dec 2018 | 151 | ||
| 1 Jan 2017 – 31 Dec 2017 | 151 | ||
| 1 Jan 2016 – 31 Dec 2016 | 149 | ||
| 1 Jan 2015 – 31 Dec 2015 | 151 | ||
| 1 Jan 2014 – 31 Dec 2014 | 153 | ||
| 1 Jan 2013 – 31 Dec 2013 | 182 | ||
| 1 Jan 2012 – 31 Dec 2012 | 156 | ||
| 1 Jan 2011 – 31 Dec 2011 | 152 | ||
| 1 Jan 2010 – 31 Dec 2010 | 150 | ||
| 1 Jan 2009 – 31 Dec 2009 | 151 | ||
| 1 Jan 2008 – 31 Dec 2008 | 148 | ||
| 1 Jan 2007 – 31 Dec 2007 | 148 | ||
| 1 Jan 2006 – 31 Dec 2006 | 155 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Lisbet Kragelund | Current | |
| CEO | Kurt Anker Nielsen | ||
| Board | Mikkel Viltoft | Current | |
| Board | Rainer Chapour Lehmann | Current | |
| Board | Lisbet Kragelund | Current | |
| Board | Mads Ravn Sørensen | ||
| Board | Mads Øvlisen | ||
| Board | Bent Hauerberg | ||
| Board | Kurt Anker Nielsen | ||
| Board | Ole Falvig Ramsby | ||
| Board | Steen Riisgaard | ||
| Board | Per Artur Fredrik Månsson | ||
| Board | Benny Dalgaard Loft | ||
| Board | Kristian Merser | ||
| Board | Peder Holk Nielsen | ||
| Board | Andrew Patrick Fordyce | ||
| Board | Tina Sejersgård Fanø | ||
| Board | Lars Green | ||
| Board | Randi Camilla Kinch Jensen | ||
| Owner (100%) | NOVOZYMES A/S | Current | |
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | PWCSP STATSAUTORISERET REVISIONSANPARTSSELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab | ||
| Auditor | Revisam | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB |
The CEOs' other companies
Lisbet Kragelund – 15 other companies
- AG-NREP Valby A/S Active
- CHR. HANSEN A/S Active
- DANICA PENSION, LIVSFORSIKRINGSAKTIESELSKAB Active
- DANSKE LEASING A/S Active
- DANSKE PRIVATE EQUITY A/S Active
- FLSMIDTH FINANS A/S Active
- FLSMIDTH MINERALS HOLDING ApS Active
- FLSMIDTH REAL ESTATE A/S Opløst
- FLSMIDTH TYSKLAND A/S Fusioneret
- FORSIKRINGSSELSKABET DANICA, SKADEFORSIKRINGSAKTIESELSKAB AF 1999 Fusioneret
- Fuller Technologies Denmark Holding ApS Active
- NOVOZYMES BIOINDUSTRIAL CHINA A/S Active
- Novonesis Plant Biosolutions A/S Active
- Novozymes Biopharma DK A/S Opløst
- SLF ROMER XV ApS Active
Kurt Anker Nielsen – 40 other companies, of which 2 bankrupt
- INCENTIVE A/S Bankrupt 17 Mar 2004
- OLICOM A/S Bankrupt 18 Jun 2010
- AKCB ApS Fusioneret
- ANPARTSSELSKABET AF 9. JANUAR 2002 Opløst
- BODENHOFF A/S Fusioneret
- COLOPLAST A/S Active
- D.C.P. AF 1988 A/S Opløst
- DAKO DENMARK ApS Active
- EJENDOMSSELSKABET SYDMARKEN 5 A/S Active
- FERROSAN ApS Active
- FERROSAN DANMARK A/S Fusioneret
- FERROSAN HOLDING A/S Fusioneret
- FERROSAN HOLDING A/S Fusioneret
- HAMELIN A/S Active
- HARNO INVEST A/S Opløst
- KAN ApS Opløst
- NNE A/S Active
- NNIT A/S Active
- NOVO NORDISK A/S Active
- NOVO NORDISK INVEST 1 A/S Opløst
- NOVO NORDISK INVEST 2 A/S Opløst
- NOVO NORDISK INVEST A/S Opløst
- NOVO NORDISK MEDICAL DEVICES A/S Fusioneret
- NOVO NORDISK PHARMACEUTICALS A/S Active
- NOVO NORDISK RESEARCH & DEVELOPMENT A/S Opløst
- NOVOZYMES A/S Active
- NOVOZYMES BIOINDUSTRIAL CHINA A/S Active
- Novo Holdings A/S Active
- Novo Nordisk Invest 3 A/S i Likvidation Opløst
- Novo Nordisk Pharmatech A/S Active
Address history (1 moves)
| Krogshøjvej 36, 2880 Bagsværd | |
| Novo Alle, 2880 Bagsværd |
Former names
| NOVOZYMES BIOINDUSTRIAL A/S | – now |
| NOVO NORDISK BIOINDUSTRIAL A/S | – |
| NOVO ENZYM A/S | – |
Other companies at the same address
- NOVOZYMES A/S Active
- NOVOZYMES ADENIUM BIOTECH A/S Fusioneret
- NOVOZYMES BIOINDUSTRIAL CHINA A/S Active
- NOVOZYMES BIOINDUSTRIAL HOLDING A/S Fusioneret
- NOVOZYMES BIOPOLYMER A/S Fusioneret
- NOVOZYMES BIOPOLYMER HOLDING A/S Fusioneret
- Novozymes Biopharma DK A/S Opløst
- Novozymes Biotechnology ApS Fusioneret
Similar companies in Gladsaxe
- JOHANSEN OG HEIDEN FINANS ApS Bagsværd
- JEBRAKA ApS Bagsværd
- OLIVER ANDERSEN HOLDING A/S Bagsværd
- CORE HOLDING ApS Søborg
- Viking Holdings ApS Søborg
- Kriterion Holding ApS Søborg
- JogS Holding ApS Kongens Lyngby
- Nordkvist Holding ApS Søborg
- Duchan Holding ApS Søborg
- Leafshore Holding ApS Søborg
- Holdingselskabet Andersen & Meldgaard ApS Søborg
- A&H Holding ApS Søborg
Questions and answers about NOVOZYMES BIOINDUSTRIAL A/S
Has NOVOZYMES BIOINDUSTRIAL A/S gone bankrupt?
No, NOVOZYMES BIOINDUSTRIAL A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of NOVOZYMES BIOINDUSTRIAL A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of NOVOZYMES BIOINDUSTRIAL A/S?
Lisbet Kragelund is the CEO of NOVOZYMES BIOINDUSTRIAL A/S.
Who is the auditor of NOVOZYMES BIOINDUSTRIAL A/S?
NOVOZYMES BIOINDUSTRIAL A/S most recently used EY Godkendt Revisionspartnerselskab.
When was NOVOZYMES BIOINDUSTRIAL A/S founded?
NOVOZYMES BIOINDUSTRIAL A/S was founded on 4 April 1974.
What is the equity of NOVOZYMES BIOINDUSTRIAL A/S?
Equity was DKK 24.9m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.